KoreaMed Synapse

Journal List > Korean J Gastroenterol > v.68(1) > 1007602

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Jeong: Can Impedance-pH Monitoring and High-resolution Manometry Predict Proton Pump Inhibitor Failure in Non-erosive Reflux Disease?

Research Update

Korean J Gastroenterol 2016;68(1):57-59.

Published online: 4 October 2016

DOI: https://doi.org/10.4166/kjg.2016.68.1.57

Can Impedance-pH Monitoring and High-resolution Manometry Predict Proton Pump Inhibitor Failure in Non-erosive Reflux Disease?

In Du Jeong

Division of Gastroenterology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Correspondence to: In Du Jeong, Division of Gastroenterology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwando-ro, Dong-gu, Ulsan 44033, Korea. Tel: +82-52-250-7029, Fax: +82-52-250-7048, E-mail: jidmd@uuh.ulsan.kr

Copyright © 2016 Korean Ophthalmological Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

Predictors of Proton Pump Inhibitor Failure in Non-erosive Reflux Disease: A Study with Impedance-pH Monitoring and High-resolution Manometry

References

1. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009; 58:295–309.

2. Shi Y, Tan N, Zhang N, et al. Predictors of proton pump inhibitor failure in non-erosive reflux disease: a study with impedance-pH monitoring and high-resolution manometry. Neurogastroenterol Motil. 2016; 28:674–679.

3. Hershcovici T, Fass R. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol. 2010; 26:367–378.

4. Kim SE, Kim N, Oh S, et al. Predictive factors of response to proton pump inhibitors in Korean patients with gastroesophageal reflux disease. J Neurogastroenterol Motil. 2015; 21:69–77.

5. Bredenoord AJ, Weusten BL, Timmer R, Conchillo JM, Smout AJ. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006; 101:453–459.

6. Sifrim D, Mittal R, Fass R, et al. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007; 25:1003–1017.

7. Farré R, van Malenstein H, De Vos R, et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut. 2008; 57:1366–1374.

8. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duode-no-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut. 2003; 52:1397–1402.

9. Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008; 103:2685–2693.

10. Zerbib F, Duriez A, Roman S, Capdepont M, Mion F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut. 2008; 57:156–160.

TOOLS

Similar articles